Next Article in Journal
Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
Next Article in Special Issue
Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis
Previous Article in Journal
Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer Models

The Unfolded Protein Response in Breast Cancer

Apoptosis Research Centre, National University of Ireland (NUI), Galway, University Road, Galway, H91 TK33 Galway, Ireland
School of Natural Sciences, NUI Galway, University Road, H91 TK33 Galway, Ireland
Department of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, 53359 Rheinbach, Germany
Author to whom correspondence should be addressed.
Cancers 2018, 10(10), 344;
Received: 3 August 2018 / Revised: 12 September 2018 / Accepted: 18 September 2018 / Published: 21 September 2018
(This article belongs to the Special Issue Cellular Stress in Cancer Progression, Drug Resistance and Treatment)
In 2018, in the US alone, it is estimated that 268,670 people will be diagnosed with breast cancer, and that 41,400 will die from it. Since breast cancers often become resistant to therapies, and certain breast cancers lack therapeutic targets, new approaches are urgently required. A cell-stress response pathway, the unfolded protein response (UPR), has emerged as a promising target for the development of novel breast cancer treatments. This pathway is activated in response to a disturbance in endoplasmic reticulum (ER) homeostasis but has diverse physiological and disease-specific functions. In breast cancer, UPR signalling promotes a malignant phenotype and can confer tumours with resistance to widely used therapies. Here, we review several roles for UPR signalling in breast cancer, highlighting UPR-mediated therapy resistance and the potential for targeting the UPR alone or in combination with existing therapies. View Full-Text
Keywords: breast cancer; endoplasmic reticulum (ER) stress; unfolded protein response (UPR); therapy; cell death; autophagy breast cancer; endoplasmic reticulum (ER) stress; unfolded protein response (UPR); therapy; cell death; autophagy
Show Figures

Figure 1

MDPI and ACS Style

McGrath, E.P.; Logue, S.E.; Mnich, K.; Deegan, S.; Jäger, R.; Gorman, A.M.; Samali, A. The Unfolded Protein Response in Breast Cancer. Cancers 2018, 10, 344.

AMA Style

McGrath EP, Logue SE, Mnich K, Deegan S, Jäger R, Gorman AM, Samali A. The Unfolded Protein Response in Breast Cancer. Cancers. 2018; 10(10):344.

Chicago/Turabian Style

McGrath, Eoghan P., Susan E. Logue, Katarzyna Mnich, Shane Deegan, Richard Jäger, Adrienne M. Gorman, and Afshin Samali. 2018. "The Unfolded Protein Response in Breast Cancer" Cancers 10, no. 10: 344.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop